The impact of blood glucose monitoring in youth aged (0-25Yr) with type 1 diabetes in managing diabetes and improving quality of life
Not Applicable
- Conditions
- Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
- Registration Number
- CTRI/2023/01/049112
- Lead Sponsor
- JDRF
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed with type 1 diabetes
Using insulin injections
No other medical condition
Exclusion Criteria
Other types of diabetes ( Type 2 diabetes, MODY, GDM, secondary diabetes )
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To quantify the impact on glycaemic control and treatment satisfaction when people living with type 1 diabetes are commenced on the SWIIM program. The primary outcome is change in HbA1c from baseline, every 3 months till 12 months. This will be reported as a change in HbA1c as mmol/mol and %. A change of 11mmol/mol (1%) will be considered significant. <br/ ><br> <br/ ><br>Timepoint: HbA1c results at baseline and every 3 months after that till the completion of the study
- Secondary Outcome Measures
Name Time Method Secondary outcomes will be the incidence of severe hypoglycaemia, diabetic ketoacidosis and hospital admissions. These will be reported as the number of episodes per 100 patient-years <br/ ><br> <br/ ><br>Timepoint: The frequency of acute complications like hypoglycemia, DKA, and admission to the hospitals will be compared prior to the start of the SWIIM programme